🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To estimate the rates of percutaneous coronary intervention (PCI) outcomes ...
Status
Completed
Location
Research Site
Start Date
2009-12
Trial ID
NCT01047176
The current follow-up study was planned to reveal the rates of Major Advers...
Status
Completed
Location
Research Site
Start Date
2014-05
Trial ID
NCT02099565
Purpose of this study is to evaluate, after implantation of a drug eluting ...
Status
Completed
Location
Cardiovascular Institute Paris Sud (ICPS)
Start Date
2014-01
Trial ID
NCT01844843
Treatments Being Tested
The purpose of this study is to determine which from the four combinations ...
Status
Unknown
Location
Cattedra di Cardiologia, Azienda Ospedaliera Universitaria di Ferrara
Start Date
2004-11
Trial ID
NCT00229515
This study is to compare clinical outcomes between quantitative coronary an...
Status
Recruiting
Location
Hallym University Sacred Heart Hospital
Start Date
2023-03-13
Trial ID
NCT05529459
Treatments Being Tested
MILESTONE STUDY is dedicated to problems connected with patients with multi...
Status
Recruiting
Location
Małopolska Cardiovascular Center, Polish-American Heart Clinic in Chrzanów
Start Date
2025-08-25
Trial ID
NCT01311323
Percutaneous coronary intervention for coronary bifurcation lesions represe...
Status
Unknown
Location
Multiple Locations
Start Date
2024-04-22
Trial ID
NCT06166459
Treatments Being Tested
The duration of dual antiplatelet treatment (i.e. asprin and clopidogrel) a...
Status
Completed
Location
Azienda Ospedaliera Universitaria di Ferrara
Start Date
2006-12
Trial ID
NCT00611286
Treatments Being Tested
This study is a prospective, open-label, two-arm, randomized multicenter tr...
Status
Completed
Location
Samsung Medical Center
Start Date
2020-08-10
Trial ID
NCT04418479
Treatments Being Tested
Longterm oral anticoagulation with very low dose rivaroxaban (2.5mg bid) in...
Status
Withdrawn
Location
University Hospital Tuebingen
Start Date
2019-07-23
Trial ID
NCT04032665
Treatments Being Tested